Interview with Anna Gajec, General Manager, Cegedim Poland
Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of…
Address: Al. Jerozolimskie 136
02-305 Warszawa
Al. Jerozolimskie 136
02-305 Warszawa
Al. Jerozolimskie 136
02-305 Warszawa
Al. Jerozolimskie 136 – 02-305 Warszawa, Poland
Tel: +48 22 389 1000
Web: http://www.cegedim.com/Pages/default.aspx
Cegedim Relationship Management helps its Life Sciences clients strengthen their customer relationships, enhance sales effectiveness, optimize data quality, improve marketing performance, and mitigate regulatory compliance risks. With a presence in more than 80 countries, Cegedim Relationship Management combines its global expertise with a deep understanding of local markets to help clients promote and market their products in the most efficient and cost-effective manner.
Leveraging our industry experience with specialized insight into commercial models and federal and state regulations, Cegedim Relationship Management offers companies of all sizes a targeted approach to optimizing growth within the evolving Life Sciences industry.
Cegedim Relationship Management provides commercial, regulatory compliance and data optimization solutions for the Life Sciences industry, enabling targeted solutions for strengthened client customer relationships, enhanced sales effectiveness, improved marketing performance and mitigated regulatory compliance risks.
Given Cegedim’s global reach and your 13 year experience of operating as a consultant to the Polish pharma industry, how would you describe the market to the international readers of…
In the pharma world, managers change frequently from one company to another, and this phenomenon has been accelerated with the consolidation of the market, however you chose to dedicate your…
Polski Holding Farmaceutyczny (PHF) was put together in 2004 as a capital group consisting of three leading Polish pharma producers and the mission given by the State Treasury Minister was…
For years Polpharma has been the market leader in Poland. In many countries the arrival of multinational companies (MNCs) led to the loss of leadership by the historical players to…
Unlike many pharmaceutical companies, Servier fully operates in all pharma business activities in Poland: research, drug manufacturing and distribution, and health education. Considering your extensive international and regional experience in…
With the current acquisition of Genzyme by Sanofi-Aventis, the French giant is planning to have Genzyme as a centre of excellence for rare diseases. Genzyme operates in the genetic market,…
Would you begin by explaining to the readers of Pharmaceutical Executive the importance of the operation in Poland for the company? Indeed Poland because of largest in CEE pharmaceutical market…
Firstly, what attracted you to join the CRO industry with Quintiles over 10 years ago? I had been working for 5 years as a doctor in the internal medicine and…
As we are just starting 2011, could you share with us the results of Nycomed Poland in 2010? In 2010, the affiliate has not been as successful as the previous…
When we look at the full year 2010 unaudited IFRS consolidated sales, we see that Ipsen performed very well in 2010 in Central and Eastern Europe. How has Poland alone…
Until very recently originator drugs had a very weak presence in central and east European countries including Poland, and there was no real patent legislation. Nevertheless, Poland has changed and…
The group has significantly invested in Poland. Are you today generally satisfied with the initial and follow up investments from Mediq in the country? The group has been present in…
Stretching across the heart of continental Europe, Poland is a massive bridge that links east and west, old and new, and which epitomizes a changing continent. At one time…
See our Cookie Privacy Policy Here
